Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3200 participants
OBSERVATIONAL
2003-02-28
2008-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
NCT05510908
Pulmonary Complications of HIV Infection Study (PACS)
NCT00005273
Study of Women Who Have AIDS
NCT00001050
Examining Factors That May Influence Resistance to HIV-1 Infection
NCT00351442
Evaluation and Monitoring of Patients With HIV Infectionn
NCT00557570
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Includes two or more full-time professional staff (e.g., social workers, nurses, clergy, physicians, or psychologists) with primary responsibility for an HIV/AIDS population.
* Has an active caseload of at least 50 people with HIV/AIDS.
* Has been in operation as an HIV/AIDS provider for at least two years.
* Has leadership and staff who are agreeable to participate in the work plan outlined in the Memorandum of Understanding (MOU).
* Working as an administrator of HIV/AIDS care services, or a direct provider of services to HIV+ patients/clients.
* Working at the agency for at least 6 months.
* Working at the agency at least 20 hours a week.
* Able to converse in English or Spanish.
* Identified by agency leadership as staff who meet above criteria and can be approached, or want to volunteer to be interviewed.
* Identified as HIV+ (according to identification by setting staff and/or by virtue of receiving services in a program exclusively designated for people infected with HIV/AIDS).
* Receiving services at an HIV/AIDS Care Setting sampled for this study, at the time of recruitment.
* Identified as a setting client for at least three months (in order to answer questions about the setting).
* Age 18 or older or emancipated minors over age 16.
* Able to converse in English or Spanish.
* Physically and mentally capable of providing informed consent, as determined by a trained interviewer.
* Identified by index patient client as "one of the people in my family most likely to participate in programs with me" at the HIV/AIDS Care Setting sampled for this study.
* Age 18 or older or emancipated minors over age 16.
* Able to converse in English or Spanish.
* Physically and mentally capable of providing informed consent, as determined by a trained interviewer.
Patients/clients will not be able to participate if they:
* Are not HIV+.
* Have been receiving services at the HIV/AIDS care setting for less than three months.
* Are under the age of 18, or are not emancipated minors.
* Are not able to converse in either English or Spanish.
* Are physically and mentally incapable of providing informed consent, as determined by a trained interviewer.
Exclusion Criteria
* Multi-site programs or programs of a single agency that are working together in a coordinated fashion for purposes of this study will be treated as a single "AIDS Care Setting." If we discover that programs are affiliated, we will remove them from the list. In general, we will attempt to carry out this project at the site initially identified, although involvement of multiple sites may be necessary.
Exclusion Consideration for Providers: All providers who are identified by the agency leadership will be approached. However, a provider will not be able to participate if he/she has already participated in the study as a provider from another agency.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Memorial Sloan-Kettering Cancer Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruce Rapkin, PhD
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan-Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
03-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.